taxonomy (9)
protein (169)
source (34)
structure (40)
composition (1)
disease (17)
reference (45)
site (265)
peptide (255)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Desmodus rotundus (Common vampire bat)
- Mus musculus (House mouse)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Columba livia (Domestic pigeon)
- Friend murine leukemia virus (F-mulv)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Adhesion G protein-coupled receptor L4 / Homo sapiens Q9HBW9
- Adhesion G-protein coupled receptor D1 / Homo sapiens Q6QNK2
- Adipocyte enhancer-binding protein 1 / Homo sapiens Q8IUX7
- Alkaline phosphatase, tissue-nonspecific isozyme / Homo sapiens P05186
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-macroglobulin / Homo sapiens P01023
- Alpha-n-acetylgalactosaminidase / Homo sapiens P17050
- Alpha-S1-casein / Homo sapiens P47710
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Apolipoprotein D / Homo sapiens P05090
- Apolipoprotein F / Homo sapiens Q13790
- Asporin / Homo sapiens Q9BXN1
- Attractin / Homo sapiens O75882
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- Biotinidase / Homo sapiens P43251
- Butyrophilin subfamily 1 member A1 / Homo sapiens Q13410
- C-type mannose receptor 2 / Homo sapiens Q9UBG0
- Cadherin-5 / Homo sapiens P33151
- Cadherin-related family member 2 / Homo sapiens Q9BYE9
- Carboxypeptidase D / Homo sapiens O75976
- Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens P06731
- Catalase / Homo sapiens P04040
- Cation-independent mannose-6-phosphate receptor / Homo sapiens P11717
- CD109 antigen / Homo sapiens Q6YHK3
- CD166 antigen / Homo sapiens Q13740
- CD59 glycoprotein / Homo sapiens P13987
- CD63 antigen / Homo sapiens P08962
- CD97 antigen / Homo sapiens P48960
- Ceruloplasmin / Homo sapiens P00450
- Cholinesterase / Homo sapiens P06276
- Chordin-like protein 2 / Homo sapiens Q6WN34
- Clusterin / Homo sapiens P10909
- Coagulation factor VIII / Homo sapiens P00451
- Coagulation factor x / Homo sapiens P00742
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Collagen alpha-3(VI) chain / Homo sapiens P12111
- Complement C1q subcomponent subunit A / Homo sapiens P02745
- Complement c1r subcomponent / Homo sapiens P00736
- Complement C2 / Homo sapiens P06681
- Complement c4-a / Homo sapiens P0C0L4
- Complement C4-B / Homo sapiens P0C0L5
- Complement factor h / Homo sapiens P08603
- Contactin-4 / Homo sapiens Q8IWV2
- Decorin / Homo sapiens P07585
- Desmoglein-2 / Homo sapiens Q14126
- Dipeptidyl peptidase 1 / Homo sapiens P53634
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens P78536
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens Q93070
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens Q9Y5L3
- Ectopic P granules protein 5 homolog / Homo sapiens Q9HCE0
- Endothelial cell-selective adhesion molecule / Homo sapiens Q96AP7
- Endothelin-converting enzyme 1 / Homo sapiens P42892
- Epidermal growth factor receptor / Homo sapiens P00533
- Epithelial cell adhesion molecule / Homo sapiens P16422
- Erythropoietin / Homo sapiens P01588
- Extracellular matrix protein 1 / Homo sapiens Q16610
- Extracellular serine/threonine protein kinase FAM20C / Homo sapiens Q8IXL6
- Fibroleukin / Homo sapiens Q14314
- Fibromodulin / Homo sapiens Q06828
- Fibronectin / Homo sapiens P02751
- Fibulin-1 / Homo sapiens P23142
- G-protein coupled receptor 126 / Homo sapiens Q86SQ4
- Galectin-3-binding protein / Homo sapiens Q08380
- Gamma-glutamyltranspeptidase 1 / Homo sapiens P19440
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- HLA class II histocompatibility antigen, DRB1-11 beta chain / Homo sapiens P20039
- HLA class II histocompatibility antigen, DRB1-13 beta chain / Homo sapiens Q5Y7A7
- HLA class II histocompatibility antigen, DRB1-14 beta chain / Homo sapiens Q9GIY3
- HLA class II histocompatibility antigen, DRB1-3 chain / Homo sapiens P01912
- Homeobox protein Hox-B3 / Homo sapiens P14651
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Immunoglobulin epsilon chain c region / Homo sapiens P01854
- Immunoglobulin gamma / Homo sapiens P01857 P01860 P01859 P01861
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Inactive tyrosine-protein kinase 7 / Homo sapiens Q13308
- Insulin receptor / Homo sapiens P06213
- Insulin-like growth factor-binding protein 3 / Homo sapiens P17936
- Integrin alpha-5 / Homo sapiens P08648
- Integrin alpha-6 / Homo sapiens P23229
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Interferon alpha/beta receptor 1 / Homo sapiens P17181
- Interleukin-6 receptor subunit beta / Homo sapiens P40189
- Kininogen-1 / Homo sapiens P01042
- Lactadherin / Homo sapiens Q08431
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-2 / Homo sapiens P24043
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Laminin subunit alpha-5 / Homo sapiens O15230
- Laminin subunit beta-1 / Homo sapiens P07942
- Laminin subunit gamma-1 / Homo sapiens P11047
- Leptin receptor / Homo sapiens P48357
- Leucine-rich alpha-2-glycoprotein / Homo sapiens P02750
- Leukocyte-associated immunoglobulin-like receptor 1 / Homo sapiens Q6GTX8
- Lipoprotein lipase / Homo sapiens P06858
- Lumican / Homo sapiens P51884
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens P07333
- Macrophage mannose receptor 1 / Homo sapiens P22897
- Macrosialin / Homo sapiens P34810
- Maltase-glucoamylase, intestinal / Homo sapiens O43451
- Matrilin-4 / Homo sapiens O95460
- Membrane primary amine oxidase / Homo sapiens Q16853
- Metal transporter CNNM4 / Homo sapiens Q6P4Q7
- Metalloproteinase inhibitor 1 / Homo sapiens P01033
- Midasin / Homo sapiens Q9NU22
- Mimecan / Homo sapiens P20774
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Oncoprotein-induced transcript 3 protein / Homo sapiens Q8WWZ8
- Pantetheinase / Homo sapiens O95497
- Periostin / Homo sapiens Q15063
- Phosphatidylcholine-sterol acyltransferase / Homo sapiens P04180
- Phospholipid transfer protein / Homo sapiens P55058
- Plasma kallikrein / Homo sapiens P03952
- Platelet glycoprotein 4 / Homo sapiens P16671
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Probable lysosomal cobalamin transporter / Homo sapiens Q9NUN5
- Prolactin-inducible protein / Homo sapiens P12273
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens P07288
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens P08575
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens P28827
- Recombinant Mucin-1 Muc1f/4tr / Homo sapiens P15941 Q99102
- Signal transducer CD24 / Homo sapiens P25063
- Sortilin-related receptor / Homo sapiens Q92673
- Target of Nesh-SH3 / Homo sapiens Q7Z7G0
- Tenascin / Homo sapiens P24821
- Thrombopoietin / Homo sapiens P40225
- Thrombospondin-1 / Homo sapiens P07996
- Thrombospondin-2 / Homo sapiens P35442
- Thrombospondin-3 / Homo sapiens P49746
- Tissue-type plasminogen activator / Homo sapiens P00750
- Transcobalamin-1 / Homo sapiens P20061
- Tubulin epsilon chain / Homo sapiens Q9UJT0
- Tumor necrosis factor receptor superfamily member 11B / Homo sapiens O00300
- Tyrosine-protein kinase receptor UFO / Homo sapiens P30530
- Uromodulin / Homo sapiens P07911
- Vitronectin / Homo sapiens P04004
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens P54289
- Von willebrand factor / Homo sapiens P04275
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Acetylcholinesterase / Bos taurus P23795
- Ribonuclease, brain / Bos taurus P39873
- Salivary plasminogen activator alpha 1 / Desmodus rotundus P98119
- Fetal antigen 1 / Mus musculus Q09163
- Zona pellucida sperm-binding protein matrix / Mus musculus P20239 Q62005 P10761
- Low density lipoprotein receptor-related protein 2 / Rattus norvegicus P98158
- Neuroligin 1 / Rattus norvegicus Q62765
- Thyroglobulin / Sus scrofa
- Immunoglobulin gamma / Columba livia
- Envelope glycoprotein / Friend murine leukemia virus P03395
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Amniotic Fluid (UBERON_0000173)
- Ascitic fluid (UBERON_0007795)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Bone Marrow (UBERON_0002371)
- Brain (UBERON_0000955)
- Colon (UBERON_0001155)
- Kidney (UBERON_0002113) BHK570 (CVCL_6370) Fibroblast (CL_0000057)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Kidney (UBERON_0002113) HEK293-EBNA (CVCL_6974)
- Liver (UBERON_0002107)
- Mammary Gland (UBERON_0001911) C127 (CVCL_6550)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Ovary (UBERON_0000992) CHO-DG44 (CVCL_7180)
- Seminal Fluid (UBERON_0006530)
- Thyroid (UBERON_0002046)
- Umbilical Vein (UBERON_0002066) HUVEC-C (CVCL_2959) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- Zona Pellucida (UBERON_0000086)
- CHO (CVCL_0213)
- Eveline (CVCL_A1LI)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- HEK293T (CVCL_0063)
- Jurkat (CVCL_0065)
- LS174T (CVCL_1384)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
- EBV-transformed B-cell (CL_0000236)
- Neutrophil (CL_0000775)
- Microsome (GO_0005792)
Source
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 587
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-4)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)Man(a1-?)[Hex(?1-?)HexNAc(?1-?)[Hex(?1-?)HexNAc(?1-?)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-2)Man(a1-?)[Gal(b1-?)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ Hex + HexNAc"
- N-Linked / Complex / Structure 2089
- N-Linked / Complex / Structure 2271
- N-Linked / Complex / Structure 9296
- N-Linked / Complex / Structure 9499
- N-Linked / Complex / Structure 9568
- N-Linked / Complex / Structure 9575
- N-Linked / Complex / Structure 9813
- N-Linked / Complex / Structure 9815
- N-Linked / Complex / Structure 9817
- N-Linked / Complex / Structure 10061
- N-Linked / Complex / Structure 10151
- N-Linked / Complex / Structure 10155
- N-Linked / Complex / Structure 10251
- N-Linked / Complex / Structure 10296
- N-Linked / Complex / Structure 10465
- N-Linked / Complex / Structure 10530
- N-Linked / Complex / Structure 10547
- N-Linked / Complex / Structure 10630
- N-Linked / Complex / Structure 10671
- N-Linked / Complex / Structure 10674
- N-Linked / Complex / Structure 10756
- N-Linked / Complex / Structure 10941
- N-Linked / Complex / Structure 10966
Reported structure
- Atopic dermatitis (DOID:3310)
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Gastritis (DOID:4029)
- Hyper IgE syndrome (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Leu83Ser) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Asp507Tyr) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Leu83Ser) (DOID:0080545)
- Hyperimmune condition
- IgE myeloma (DOID:9538)
- Mixed phenotype acute leukemia (DOID:9953)
- Myeloma, Multiple (DOID:9538)
- Prostate cancer (DOID:10283)
- T-cell childhood acute lymphocytic leukemia (DOID:0080145)
Disease
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. (2021 - Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D) / Status : Reviewed
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (2020 - Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch, Melinda A. Brindley, Nathan E. Lewis, Michael Tiemeyer, Bing Chen, Robert J. Woods, Lance Wells) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. (2019 - Martina Pirro, Esmee Schoof, Sandra J. van Vliet, Yoann Rombouts, Alexandre Stella, Arnoud de Ru, Yassene Mohammed, Manfred Wuhrer, Peter A. van Veelen, Paul J. Hensbergen) / Status : Reviewed
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins (2015 - Qiuting Hong, L. Renee Ruhaak, Carol Stroble, Evan Parker, Jincui Huang, Emanual Maverakis, Carlito B. Lebrilla) / Status : Reviewed
- The serum immunoglobulin G glycosylation signature of gastric cancer (2015 - L. Renee Ruhaak, Donald A. Barkauskas, Javier Torres, Cara L. Cooke, Lauren D. Wu, Carol Stroble, Sureyya Ozcan, Cynthia C. Williams, Margarita Camorlinga, David M. Rocke, Carlito B. Lebrilla, Jay V. Solnick,) / Status : Reviewed
- A single glycan on IgE is indispensable for initiation of anaphylaxis (2015 - Kai-Ting C. Shade, Barbara Platzer, Nathaniel Washburn, Vinidhra Mani, Yannic C. Bartsch, Michelle Conroy, Jose D. Pagan, Carlos Bosques, Thorsten R. Mempel, Edda Fiebiger, Robert M. Anthony) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Determination of site-specific glycan heterogeneity on glycoproteins (2012 - Kolarich D1, Jensen PH, Altmann F, Packer NH.) / Status : Reviewed
- Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. (2004 - Hoffman RC, Jennings LL, Tsigelny I, Comoletti D, Flynn RE, Sudhof TC, Taylor P) / Status : Reviewed
- N-glycan structures of pigeon IgG: a major serum glycoprotein containing Galalpha1-4 Gal termini.. (2003 - Suzuki N, Khoo KH, Chen CM, Chen HC, Lee YC) / Status : Reviewed
- Human alpha-N-acetylgalactosaminidase: site occupancy and structure of N-linked oligosaccharides. (2000 - Ohta M, Ohnishi T, Ioannou Y, Hodgson M, Matsuura F, Desnick R) / Status : Reviewed
- Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed
- Structural analysis of murine zona pellucida glycans. Evidence for the expression of core 2-type O-glycans and the Sd(a) antigen. (2000 - Easton RL, Patankar MS, Lattanzio FA, Leaven TH, Morris HR, Clark GF, Dell A) / Status : Reviewed
- Characterization of the N-linked oligosaccharides of megalin (gp330) from rat kidney. (2000 - Morelle W, Haslam S, Ziak M, Roth J, Morris H, Dell A) / Status : Reviewed
- Characterization of human vascular endothelial cadherin glycans. (1999 - Geyer H, Geyer R, Odenthal-Schnittler M, Schnittler H) / Status : Reviewed
- Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. (1997 - Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P, Reutter W) / Status : Reviewed
- Glycosylation analysis and protein structure determination of murine fetal antigen 1 (mFA1)--the circulating gene product of the delta-like protein (dlk), preadipocyte factor 1 (Pref-1) and stromal-cell-derived protein 1 (SCP-1) cDNAs. (1997 - Krogh T, Bachmann E, Teisner B, Skjdt K, Hjrup P) / Status : Reviewed
- Elucidation of N-linked oligosaccharide structures of recombinant human factor VIII using fluorophore-assisted carbohydrate electrophoresis. (1996 - Kumar H, Hague C, Haley T, Starr C, Besman M, Lundblad R, Baker D) / Status : Reviewed
- Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246. (1996 - Hoffman RC, Andersen H, Walker K, Krakover JD, Patel S, Stamm MR, Osborn SG) / Status : Reviewed
- Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. (1995 - Nakagawa H, Takahashi N, Fujikawa K, Kawamura Y, Iino M, Takeya H, Ogawa H, Suzuki K) / Status : Reviewed
- Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. (1994 - Sutton C, O'Neill J, Cottrell J) / Status : Reviewed
- Structure determination by 1H NMR spectroscopy of (sulfated) sialylated N-linked carbohydrate chains released from porcine thyroglobulin by peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase-F. (1991 - de Waard P, Koorevaar A, Kamerling J, Vliegenthart J) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cells. (1990 - Nimtz M, Noll G, Pques E, Conradt H) / Status : Reviewed
- Carbohydrate structure of recombinant human uterine tissue plasminogen activator expressed in mouse epithelial cells. (1989 - Pfeiffer G, Schmidt M, Strube K, Geyer R) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Adhesion G protein-coupled receptor L4 / Homo sapiens
- Adhesion G-protein coupled receptor D1 / Homo sapiens
- Adipocyte enhancer-binding protein 1 / Homo sapiens
- Alkaline phosphatase, tissue-nonspecific isozyme / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
-
Alpha-n-acetylgalactosaminidase / Homo sapiens
- Undefined site
- Alpha-S1-casein / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Apolipoprotein D / Homo sapiens
- Apolipoprotein F / Homo sapiens
- Asporin / Homo sapiens
- Attractin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Biotinidase / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
-
Cadherin-5 / Homo sapiens
- Undefined site
- Cadherin-related family member 2 / Homo sapiens
- Carboxypeptidase D / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- Catalase / Homo sapiens
- Cation-independent mannose-6-phosphate receptor / Homo sapiens
- CD109 antigen / Homo sapiens
- CD166 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- CD63 antigen / Homo sapiens
- CD97 antigen / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Cholinesterase / Homo sapiens
- Chordin-like protein 2 / Homo sapiens
- Clusterin / Homo sapiens
-
Coagulation factor VIII / Homo sapiens
- Undefined site
- Coagulation factor x / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement C1q subcomponent subunit A / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Complement C2 / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Complement factor h / Homo sapiens
- Contactin-4 / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Ectopic P granules protein 5 homolog / Homo sapiens
- Endothelial cell-selective adhesion molecule / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- Erythropoietin / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Extracellular serine/threonine protein kinase FAM20C / Homo sapiens
- Fibroleukin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Fibulin-1 / Homo sapiens
- G-protein coupled receptor 126 / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-11 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-13 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-14 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-3 chain / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin epsilon chain c region / Homo sapiens
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Undefined site
- Asn-340
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Insulin receptor / Homo sapiens
- Insulin-like growth factor-binding protein 3 / Homo sapiens
- Integrin alpha-5 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Interferon alpha/beta receptor 1 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactadherin / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit beta-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Leptin receptor / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Leukocyte-associated immunoglobulin-like receptor 1 / Homo sapiens
- Lipoprotein lipase / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Macrosialin / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Matrilin-4 / Homo sapiens
- Membrane primary amine oxidase / Homo sapiens
- Metal transporter CNNM4 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Midasin / Homo sapiens
- Mimecan / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Oncoprotein-induced transcript 3 protein / Homo sapiens
- Pantetheinase / Homo sapiens
- Periostin / Homo sapiens
- Phosphatidylcholine-sterol acyltransferase / Homo sapiens
- Phospholipid transfer protein / Homo sapiens
- Plasma kallikrein / Homo sapiens
- Platelet glycoprotein 4 / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Probable lysosomal cobalamin transporter / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens
- Recombinant Mucin-1 Muc1f/4tr / Homo sapiens
- Signal transducer CD24 / Homo sapiens
- Sortilin-related receptor / Homo sapiens
- Target of Nesh-SH3 / Homo sapiens
- Tenascin / Homo sapiens
-
Thrombopoietin / Homo sapiens
- Undefined site
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Thrombospondin-3 / Homo sapiens
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
- Transcobalamin-1 / Homo sapiens
- Tubulin epsilon chain / Homo sapiens
- Tumor necrosis factor receptor superfamily member 11B / Homo sapiens
- Tyrosine-protein kinase receptor UFO / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens
- Von willebrand factor / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Acetylcholinesterase / Bos taurus
- Undefined site
- Ribonuclease, brain / Bos taurus
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
- Fetal antigen 1 / Mus musculus
-
Zona pellucida sperm-binding protein matrix / Mus musculus
- Undefined site
-
Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
- Undefined site
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
Thyroglobulin / Sus scrofa
- Undefined site
-
Immunoglobulin gamma / Columba livia
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LELNLTDSENATCLYAK (17aa)
- LVPVPITNATLDQITGK (17aa)
- LVPVPITNATLDR (13aa)
- KRQSGVNATLPEENQPVVFNHVYNIKL (27aa)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- FIEYSTSECHFFNGTER (17aa)
- P01912 Asn-48     HLA class II histocompatibility antigen, DRB1-3 chain / Homo sapiens
- P20039 Asn-48     HLA class II histocompatibility antigen, DRB1-11 beta chain / Homo sapiens
- Q9GIY3 Asn-48     HLA class II histocompatibility antigen, DRB1-14 beta chain / Homo sapiens
- Q5Y7A7 Asn-48     HLA class II histocompatibility antigen, DRB1-13 beta chain / Homo sapiens
- WQMNFTVR (8aa)
- WFSAGLASNSSWLR (14aa)
- EAENITTGC (9aa)
- APNPTNATTK (10aa)
- RLSPNASAEHLELRW (15aa)
- YETTNK (6aa)
- EGHFYYNISEVK (12aa)
- SLNENITVPDTK (12aa)
- CIQANYSIMENGK (13aa)
- NKSVLLGR (8aa)
- STYNDTEDVSQASPSESEAR (20aa)
- GLNVGPNATR (10aa)
- AIGFENATQAIGR (13aa)
- KDTRNESTQNCVVAEPEKM (19aa)
- RTPEDTAEDTCHLIPGVAESVATCHFNHSSKT (32aa)
- AEMNGSK (7aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- NQNGTFK (7aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- KEDALNETR (9aa)
- NNATVHEQVGGPSLTSDLQAQSK (23aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- KEDALNETRESETKL (15aa)
- KKEDALNETRESETKL (16aa)
- KEDALNETRE (10aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- QDQCIYNTTYLNVQR (15aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- CATPHGDNASIEATFVK (17aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- IAVQFGPGFSWIANFTK (17aa)
- ENDTHCIDFSYLLYSQK (17aa)
- RSHNRSEEFLIAGKL (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- LPGVCNETMMALWEECKPCLK (21aa)
- TFYWDFYTNR (10aa)
- GQALLVNSSQPWEPLQLHVDK (21aa)
- KSCQHNGTMYQHGEIFSAHELFPSRL (26aa)
- QACASFNGNCCLWNTTVEVK (20aa)
- SANASFNIK (9aa)
- GLCVNASAVSR (11aa)
- QGGVNATQVLIQHLR (15aa)
- TQDEIIFSNSTR (12aa)
- TQSLLIVNNATNVVIK (16aa)
- MLLTFHTDFSNEENGTIMFYK (21aa)
- HINHNNLTESVGPLPK (16aa)
- GNTSGVIVVITK (12aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- KLHINHNNLTESVGPLPKS (19aa)
- RTLNQSSDELQLSMGNAMFVKE (22aa)
- FGCEIENNR (9aa)
- NNSIYVVANIGDK (13aa)
- KNNHTASILDRM (12aa)
- KNNHTASILDRMQADFKC (18aa)
- NLSCIVNEGK (10aa)
- VNNGPLGNPIWNISGDPTR (19aa)
- NHSYHVEGNLVNTNAGFTAR (20aa)
- NFTEVEENMSVQGGLSESAPQSNFSYTQPAMENIQVR (37aa)
- EHEGAIYPDNTTDFQR (16aa)
- VVIFDTVITNQEEPYQNHSGR (21aa)
- RNPPMGGNVVIFDTVITNQEEPYQNHSGR (29aa)
- FNDTEVLQR (9aa)
- HTNYSFSPWHGFTIHR (16aa)
- RRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (33aa)
- RTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (32aa)
- IGSFEGIVNITFIHIQHNR (19aa)
- VYKPSAGNNSLYR (13aa)
- NNCLLK (6aa)
- VYSSANNCTFE (11aa)
- IYIDHNNITR (10aa)
- GNFSTEGCGCVCEPGWK (17aa)
- NGSLFAFR (8aa)
- IYVIDGTQNDTAFVFPR (17aa)
- DSIMENGTLCYEVHYR (16aa)
- VANITFVVNSIDGK (14aa)
- KGPNCSEPECPGNCHLRG (18aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- ACMNETR (7aa)
- SWPAVGNCSSALR (13aa)
- VMYTTQGGGEAWGISVLNPNK (21aa)
- AWGISVLNPNK (11aa)
- ITYSIVQTNCSK (12aa)
- TPLTANITK (9aa)
- GLTFQQNASSMCGPDQDTAIR (21aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- KNLFLNHSENATAKD (15aa)
- GSLSLTNLSSSMAGVYVCK (19aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- LNNLTFLYLDHNALESVPLNLPESLR (26aa)
- TNSTFVQALVEHVK (14aa)
- KNVSCYIQNLLLGQEKK (17aa)
- VEMANLLNLSER (12aa)
- YANITVDYLYNK (12aa)
- YANITVDYLYNKETK (15aa)
- VVLHPNYSQVDIGLIK (16aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- FHLANR (6aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- LTLDNNVVNGSSPAIR (16aa)
- KDNTTVTR (8aa)
- TTEFDTNSTDIALK (14aa)
- WDYTYANMTFQVQWLHAFLK (20aa)
- VASVININPNTTHSTGSCR (19aa)
- IININPNK (8aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- LGLSFNSISAVDNGSLANTPH (21aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- NAIKEGDNITIK (12aa)
- EGDNITIK (8aa)
- MIENGSISFIPTIR (14aa)
- YIGNATAIFFIPDEGK (16aa)
- KYTGNASALFILPDQDKM (18aa)
- LNSSTIK (7aa)
- IITNNSQTPIISPQEVVSCSQYAQGCEGGFPYIIAGK (37aa)
- ITDIENGSIANIPR (14aa)
- NGTITDAVDCALDPLSE (17aa)
- NVSVAEGK (8aa)
- RHIGHANLTFEQLRS (15aa)
- REIRHNSTGCLRM (13aa)
- LNAENNATFYFK (12aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- MAWPEDHVFISTPSFNYTGR (20aa)
- ELDLTCNITTDR (12aa)
- VNGSLDR (7aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- NATGDYK (7aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- LHSNNITK (8aa)
- NETLALPAESK (11aa)
- KNCTSYGVLDISKC (14aa)
- AANGSLR (7aa)
- MFSQNDTR (8aa)
- KVAYSNDSANWTEYQDPRT (19aa)
- FFAENETWVVDSCTTCTCK (19aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- FPNITNLCPFGE (12aa)
- IIDNNKTEK (9aa)
- DHENGTGTNTYAALNSVYLMMNNQMR (26aa)
- MVNMTK (6aa)
- IHVGNYNGTAGDAIR (15aa)
- NIETFTCDTQNITYR (15aa)
- LAGKPTHVNVSVVMAEVDGTC (21aa)
- RLAGKPTHVNVSVVMAEVDGTCY- (24aa)
- LAGKPTHVNVSVVMAEVDGTCY (22aa)
- GEVFNATR (8aa)
- VFNATR (6aa)
- NGSQAFVHWQEPR (13aa)
- QGNNHTCTWK (10aa)
- KMLNTSSLLEQLNEQFNWVSRL (22aa)
- VQPFNVTQGK (10aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- NATVVWMK (8aa)
- DASSFIAEWQNITK (14aa)
- KMNDTIFGFTMEERS (15aa)
- RLANLTQGEDQYYLRV (16aa)
- EWIPINR (7aa)
- TVNSSHYR (8aa)
- GLNLTEDTYKPR (12aa)
- NNTCVK (6aa)
- RQDVNITVATVPSWIK (16aa)
- IGFIGNQSQGCIPAR (15aa)
- VAEAVSSPAGVGVTWIEPDYQVYINASK (28aa)
- INYTVPQSGTFK (12aa)
- RLSLLEEPGNGTFTVILNQLTSRD (24aa)
- ENVSMVDYAHNNYQAQSAVPLR (22aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- HNLTITQGK (9aa)
- ISAVNSIFISHNNTK (15aa)
- YVQNGTYTVK (10aa)
- APQHVVNHLPPYTNVSLK (18aa)
- KVPGNVTAVLGETLKV (16aa)
- FGNETFIIHLDNGR (14aa)
- IIISPEENVTITCTAENQIER (21aa)
- NFTEVHPDYGSHIQALLDK (19aa)
- WNDSPCNQSLPSICK (15aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KSCHTAVDRTAGWNIPMGLLFNQTGSCKF (29aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- NNESLDEGLR (10aa)
- YGNPNETQNNSTSWPVFK (18aa)
- LHNQLLPNVTTVER (14aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- FANEYPNITR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- IYPITWNGSICMR (13aa)
- EQMEVVNMSLSTSADSLTTPR (21aa)
- CQEAINATCK (10aa)
- AAIPSAIDTNSSK (13aa)
- KAAIPSALDTNSSKS (15aa)
- YIYIASNHSNK (11aa)
- EVNDTLLVNELK (12aa)
- MAEVIGSKLNISR (13aa)
- IQMISFAGEPIPQNSSMAR (19aa)
- LDGLGYWSNWSNPAYTVVMDIK (22aa)
- TEGENCTVFDSQAGFSFDLSPLTK (24aa)
- KFGRNGSDCPDKF (13aa)
- RNGSDCPDKF (10aa)
- NNSYECDIPI (10aa)
- ISDNNTEFLLNFNEFIDR (18aa)
- GTNYTVR (7aa)
- IETILLNGTDR (11aa)
- LITEEANR (8aa)
- ELHHLQEQNVSNAFLDK (17aa)
- KELHHLQEQNVSNAFLDKG (19aa)
- QISCVANQNGSQADCEIGNPFKR (23aa)
- NLNNSQSDVVSFR (13aa)
- NMTLFSDLVAEK (12aa)
- DNIGSQYLLNWCVQIAK (17aa)
- LSALDNLLNHSSMFLK (16aa)
- TVGNQTSTK (9aa)
- VINETWAWK (9aa)
- IPCSQPPQIEHGTINSSR (18aa)
- ISEENETTCYMGK (13aa)
- ALDNESEVK (9aa)
- VVNSTTGPGEHIR (13aa)
- VPAQEKNF (8aa)
- NGTHWFVT (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- TEAGAFEYVPDPTFENFTGGVK (22aa)
- KTAHCNESFYFLCKR (15aa)
- TIAGENQTAFEIEEINR (17aa)
- NISQDLEK (8aa)
- LSDTTSQSNSTAK (13aa)
- WTPINSSTIIGYR (13aa)
- RGLNVTLSSTGRN (13aa)
- VNASTTEPNSTVEQSALMR (19aa)
- VEAAQNLTLPGSLR (14aa)
- VEAAQNITIPGSIR (14aa)
- KVEAAQNLTLPGSLRA (16aa)
- VSNQTLSLFFTVLQDVPVR (19aa)
- RLLETVEYNISGAERT (16aa)
- IIETVEYNISGAER (14aa)
- DNTTCYEFK (9aa)
- KRNDQLPSNFTPVFYSQLQKN (21aa)
- GFEESEPVSGSFTTAIDGPSGIVTANITDSEAIAR (35aa)
- NMTALEK (7aa)
- NSTTLVMHMK (10aa)
- HCDGNVSSCGDHPSEGCFCPPDK (23aa)
- AQQIIANSTAIEEAMIQEQQR (21aa)
- VAVVQHAPSESVDNASMPPVK (21aa)
- GCHINECLSR (10aa)
- TCPIDEFQCNNTICKPIAWK (20aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Microsome (GO_0005792)
-
Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Blood Plasma (UBERON_0001969)
- Vitronectin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2444.2456)
-
Immunoglobulin gamma / Columba livia
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- Carbohydrate structure of recombinant human uterine tissue plasminogen activator expressed in mouse epithelial cells. (1989 - Pfeiffer G, Schmidt M, Strube K, Geyer R) / Status : Reviewed
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
- Ribonuclease, brain / Bos taurus
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Human alpha-N-acetylgalactosaminidase: site occupancy and structure of N-linked oligosaccharides. (2000 - Ohta M, Ohnishi T, Ioannou Y, Hodgson M, Matsuura F, Desnick R) / Status : Reviewed
- Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. (1997 - Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P, Reutter W) / Status : Reviewed
-
Alpha-n-acetylgalactosaminidase / Homo sapiens
- Undefined site
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. (1995 - Nakagawa H, Takahashi N, Fujikawa K, Kawamura Y, Iino M, Takeya H, Ogawa H, Suzuki K) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- Coagulation factor x / Homo sapiens
- Ribonuclease, brain / Bos taurus
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Human alpha-N-acetylgalactosaminidase: site occupancy and structure of N-linked oligosaccharides. (2000 - Ohta M, Ohnishi T, Ioannou Y, Hodgson M, Matsuura F, Desnick R) / Status : Reviewed
- Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. (1997 - Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P, Reutter W) / Status : Reviewed
- Elucidation of N-linked oligosaccharide structures of recombinant human factor VIII using fluorophore-assisted carbohydrate electrophoresis. (1996 - Kumar H, Hague C, Haley T, Starr C, Besman M, Lundblad R, Baker D) / Status : Reviewed
- Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cells. (1990 - Nimtz M, Noll G, Pques E, Conradt H) / Status : Reviewed
-
Alpha-n-acetylgalactosaminidase / Homo sapiens
- Undefined site
-
Coagulation factor VIII / Homo sapiens
- Undefined site
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Zona Pellucida (UBERON_0000086)
-
Zona pellucida sperm-binding protein matrix / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Umbilical Vein (UBERON_0002066) HUVEC-C (CVCL_2959) Endothelial Cell of Umbilical Vein (CL_0002618)
-
Cadherin-5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
-
Thrombopoietin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Thyroid (UBERON_0002046)
-
Thyroglobulin / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Amniotic Fluid (UBERON_0000173)
- Fetal antigen 1 / Mus musculus
-
- N-Linked / Complex
(avg mass : 2444.2456)
- A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins (2015 - Qiuting Hong, L. Renee Ruhaak, Carol Stroble, Evan Parker, Jincui Huang, Emanual Maverakis, Carlito B. Lebrilla) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
- Immunoglobulin epsilon chain c region / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Erythropoietin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Erythropoietin / Homo sapiens
- EAENITTGC (9aa)
- SLNENITVPDTK (12aa)
- GQALLVNSSQPWEPLQLHVDK (21aa)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Milk (UBERON_0001913)
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-S1-casein / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- CD63 antigen / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Chordin-like protein 2 / Homo sapiens
- Clusterin / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Haptoglobin / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Lactadherin / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lipoprotein lipase / Homo sapiens
- Lumican / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Platelet glycoprotein 4 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Recombinant Mucin-1 Muc1f/4tr / Homo sapiens
- Tenascin / Homo sapiens
- Transcobalamin-1 / Homo sapiens
- Tumor necrosis factor receptor superfamily member 11B / Homo sapiens
- KRQSGVNATLPEENQPVVFNHVYNIKL (27aa)
- RLSPNASAEHLELRW (15aa)
- KDTRNESTQNCVVAEPEKM (19aa)
- RTPEDTAEDTCHLIPGVAESVATCHFNHSSKT (32aa)
- KEDALNETRESETKL (15aa)
- KKEDALNETRESETKL (16aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- KEDALNETRE (10aa)
- RSHNRSEEFLIAGKL (15aa)
- KSCQHNGTMYQHGEIFSAHELFPSRL (26aa)
- RTLNQSSDELQLSMGNAMFVKE (22aa)
- KLHINHNNLTESVGPLPKS (19aa)
- KNNHTASILDRMQADFKC (18aa)
- KNNHTASILDRM (12aa)
- RTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (32aa)
- RRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (33aa)
- KGPNCSEPECPGNCHLRG (18aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- KNLFLNHSENATAKD (15aa)
- KNVSCYIQNLLLGQEKK (17aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- KYTGNASALFILPDQDKM (18aa)
- RHIGHANLTFEQLRS (15aa)
- REIRHNSTGCLRM (13aa)
- KNCTSYGVLDISKC (14aa)
- KVAYSNDSANWTEYQDPRT (19aa)
- RLAGKPTHVNVSVVMAEVDGTCY- (24aa)
- KMLNTSSLLEQLNEQFNWVSRL (22aa)
- KMNDTIFGFTMEERS (15aa)
- RLANLTQGEDQYYLRV (16aa)
- RLSLLEEPGNGTFTVILNQLTSRD (24aa)
- KVPGNVTAVLGETLKV (16aa)
- KSCHTAVDRTAGWNIPMGLLFNQTGSCKF (29aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- KAAIPSALDTNSSKS (15aa)
- KFGRNGSDCPDKF (13aa)
- RNGSDCPDKF (10aa)
- KELHHLQEQNVSNAFLDKG (19aa)
- KTAHCNESFYFLCKR (15aa)
- RGLNVTLSSTGRN (13aa)
- KVEAAQNLTLPGSLRA (16aa)
- RLLETVEYNISGAERT (16aa)
- KRNDQLPSNFTPVFYSQLQKN (21aa)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2444.2456)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- CHO (CVCL_0213)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- VFNATR (6aa)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Atopic dermatitis (DOID:3310)
- Control/Healthy
- Hyper IgE syndrome (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Leu83Ser) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Asp507Tyr) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Leu83Ser) (DOID:0080545)
-
Immunoglobulin epsilon chain c region / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Ascitic fluid (UBERON_0007795)
- Colon (UBERON_0001155)
- Liver (UBERON_0002107)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Bone Marrow (UBERON_0002371)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Bone Marrow (UBERON_0002371)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Bone Marrow (UBERON_0002371)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Blood Plasma (UBERON_0001969)
- Myeloma, Multiple (DOID:9538)
-
Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2444.2456)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- NKSVLLGR (8aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Jurkat (CVCL_0065)
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 587
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-4)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)Man(a1-?)[Hex(?1-?)HexNAc(?1-?)[Hex(?1-?)HexNAc(?1-?)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-2)Man(a1-?)[Gal(b1-?)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc+"+ Hex + HexNAc"
- N-Linked / Complex / Structure 2089
- N-Linked / Complex / Structure 2271
- N-Linked / Complex / Structure 9296
- N-Linked / Complex / Structure 9499
- N-Linked / Complex / Structure 9568
- N-Linked / Complex / Structure 9575
- N-Linked / Complex / Structure 9813
- N-Linked / Complex / Structure 9815
- N-Linked / Complex / Structure 9817
- N-Linked / Complex / Structure 10061
- N-Linked / Complex / Structure 10151
- N-Linked / Complex / Structure 10155
- N-Linked / Complex / Structure 10251
- N-Linked / Complex / Structure 10296
- N-Linked / Complex / Structure 10465
- N-Linked / Complex / Structure 10530
- N-Linked / Complex / Structure 10547
- N-Linked / Complex / Structure 10630
- N-Linked / Complex / Structure 10671
- N-Linked / Complex / Structure 10674
- N-Linked / Complex / Structure 10756
- N-Linked / Complex / Structure 10941
- N-Linked / Complex / Structure 10966
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Gastritis (DOID:4029)
- Prostate cancer (DOID:10283)
- T-cell childhood acute lymphocytic leukemia (DOID:0080145)
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. (2019 - Martina Pirro, Esmee Schoof, Sandra J. van Vliet, Yoann Rombouts, Alexandre Stella, Arnoud de Ru, Yassene Mohammed, Manfred Wuhrer, Peter A. van Veelen, Paul J. Hensbergen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- The serum immunoglobulin G glycosylation signature of gastric cancer (2015 - L. Renee Ruhaak, Donald A. Barkauskas, Javier Torres, Cara L. Cooke, Lauren D. Wu, Carol Stroble, Sureyya Ozcan, Cynthia C. Williams, Margarita Camorlinga, David M. Rocke, Carlito B. Lebrilla, Jay V. Solnick,) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Adhesion G protein-coupled receptor L4 / Homo sapiens
- Adhesion G-protein coupled receptor D1 / Homo sapiens
- Adipocyte enhancer-binding protein 1 / Homo sapiens
- Alkaline phosphatase, tissue-nonspecific isozyme / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Apolipoprotein F / Homo sapiens
- Asporin / Homo sapiens
- Attractin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Biotinidase / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
- Cadherin-related family member 2 / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- Catalase / Homo sapiens
- Cation-independent mannose-6-phosphate receptor / Homo sapiens
- CD109 antigen / Homo sapiens
- CD166 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- CD97 antigen / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Cholinesterase / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement C1q subcomponent subunit A / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Complement C2 / Homo sapiens
- Complement factor h / Homo sapiens
- Contactin-4 / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Ectopic P granules protein 5 homolog / Homo sapiens
- Endothelial cell-selective adhesion molecule / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Extracellular serine/threonine protein kinase FAM20C / Homo sapiens
- Fibroleukin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Fibulin-1 / Homo sapiens
- G-protein coupled receptor 126 / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-11 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-13 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-14 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-3 chain / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Insulin receptor / Homo sapiens
- Insulin-like growth factor-binding protein 3 / Homo sapiens
- Integrin alpha-5 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Interferon alpha/beta receptor 1 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit beta-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Leptin receptor / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Leukocyte-associated immunoglobulin-like receptor 1 / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens
- Macrosialin / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Matrilin-4 / Homo sapiens
- Membrane primary amine oxidase / Homo sapiens
- Metal transporter CNNM4 / Homo sapiens
- Midasin / Homo sapiens
- Mimecan / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Oncoprotein-induced transcript 3 protein / Homo sapiens
- Pantetheinase / Homo sapiens
- Periostin / Homo sapiens
- Phosphatidylcholine-sterol acyltransferase / Homo sapiens
- Phospholipid transfer protein / Homo sapiens
- Plasma kallikrein / Homo sapiens
- Plexin-B2 / Homo sapiens
- Probable lysosomal cobalamin transporter / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens
- Signal transducer CD24 / Homo sapiens
- Sortilin-related receptor / Homo sapiens
- Target of Nesh-SH3 / Homo sapiens
- Tenascin / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Thrombospondin-3 / Homo sapiens
- Tubulin epsilon chain / Homo sapiens
- Tyrosine-protein kinase receptor UFO / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens
- Von willebrand factor / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LELNLTDSENATCLYAK (17aa)
- LVPVPITNATLDQITGK (17aa)
- LVPVPITNATLDR (13aa)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- FIEYSTSECHFFNGTER (17aa)
- P01912 Asn-48     HLA class II histocompatibility antigen, DRB1-3 chain / Homo sapiens
- P20039 Asn-48     HLA class II histocompatibility antigen, DRB1-11 beta chain / Homo sapiens
- Q9GIY3 Asn-48     HLA class II histocompatibility antigen, DRB1-14 beta chain / Homo sapiens
- Q5Y7A7 Asn-48     HLA class II histocompatibility antigen, DRB1-13 beta chain / Homo sapiens
- WQMNFTVR (8aa)
- WFSAGLASNSSWLR (14aa)
- APNPTNATTK (10aa)
- YETTNK (6aa)
- EGHFYYNISEVK (12aa)
- CIQANYSIMENGK (13aa)
- STYNDTEDVSQASPSESEAR (20aa)
- GLNVGPNATR (10aa)
- AIGFENATQAIGR (13aa)
- AEMNGSK (7aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- NQNGTFK (7aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- KEDALNETR (9aa)
- NNATVHEQVGGPSLTSDLQAQSK (23aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- QDQCIYNTTYLNVQR (15aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- CATPHGDNASIEATFVK (17aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- IAVQFGPGFSWIANFTK (17aa)
- ENDTHCIDFSYLLYSQK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- LPGVCNETMMALWEECKPCLK (21aa)
- TFYWDFYTNR (10aa)
- QACASFNGNCCLWNTTVEVK (20aa)
- SANASFNIK (9aa)
- GLCVNASAVSR (11aa)
- QGGVNATQVLIQHLR (15aa)
- TQDEIIFSNSTR (12aa)
- MLLTFHTDFSNEENGTIMFYK (21aa)
- HINHNNLTESVGPLPK (16aa)
- GNTSGVIVVITK (12aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FGCEIENNR (9aa)
- NNSIYVVANIGDK (13aa)
- NLSCIVNEGK (10aa)
- VNNGPLGNPIWNISGDPTR (19aa)
- NHSYHVEGNLVNTNAGFTAR (20aa)
- NFTEVEENMSVQGGLSESAPQSNFSYTQPAMENIQVR (37aa)
- EHEGAIYPDNTTDFQR (16aa)
- VVIFDTVITNQEEPYQNHSGR (21aa)
- RNPPMGGNVVIFDTVITNQEEPYQNHSGR (29aa)
- FNDTEVLQR (9aa)
- HTNYSFSPWHGFTIHR (16aa)
- IGSFEGIVNITFIHIQHNR (19aa)
- VYKPSAGNNSLYR (13aa)
- NNCLLK (6aa)
- IYIDHNNITR (10aa)
- GNFSTEGCGCVCEPGWK (17aa)
- NGSLFAFR (8aa)
- IYVIDGTQNDTAFVFPR (17aa)
- DSIMENGTLCYEVHYR (16aa)
- VANITFVVNSIDGK (14aa)
- ACMNETR (7aa)
- SWPAVGNCSSALR (13aa)
- VMYTTQGGGEAWGISVLNPNK (21aa)
- AWGISVLNPNK (11aa)
- ITYSIVQTNCSK (12aa)
- TPLTANITK (9aa)
- GLTFQQNASSMCGPDQDTAIR (21aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- GSLSLTNLSSSMAGVYVCK (19aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- LNNLTFLYLDHNALESVPLNLPESLR (26aa)
- TNSTFVQALVEHVK (14aa)
- VEMANLLNLSER (12aa)
- YANITVDYLYNK (12aa)
- YANITVDYLYNKETK (15aa)
- VVLHPNYSQVDIGLIK (16aa)
- FHLANR (6aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- LTLDNNVVNGSSPAIR (16aa)
- KDNTTVTR (8aa)
- TTEFDTNSTDIALK (14aa)
- WDYTYANMTFQVQWLHAFLK (20aa)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2444.2456)
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2444.2456)